Company Analysis

Cytosorbents Corporation (CTSO)

Nasdaq: CTSO · Surgical & Medical Instruments & Apparatus · Princeton, NJ · filing with the SEC since 2004
Grade4.2
◀ Past 3.0● Present 4.8▶ Future 4.6
1 est.

Filings

320 filings since 2017 beside 208 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026
Due nextNon-accelerated filer and smaller reporting company
10-Q Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by Nov 14, 2026
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed Jun 25, 2026.

Filings a yearinsider forms included
5751526256565826
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Listing warning from its exchange (8-K item 3.01): 5 times in the last 36 months, the newest Jul 6, 2026.Warning not to rely on past financial statements (8-K item 4.02): 1 time in the last 36 months, the newest Mar 31, 2025.Officer or director change (8-K item 5.02): 2 times in the last 36 months, the newest Aug 16, 2024.SEC letters: 2 in the last 36 months, the newest Sep 27, 2024.
Insider forms 208

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 12, 2026 8-K items 2.02, 9.01 Results released · Current report
Sep 23, 2026 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report Sep 22, 2026
Sep 8, 2026 8-K items 5.03, 9.01 Charter, bylaw or fiscal-year change · Current report
Aug 14, 2026 8-K item 5.07 Shareholder vote · Current report Aug 13, 2026
Aug 7, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report Aug 6, 2026
Aug 6, 2026 8-K items 2.02, 9.01 Results released · Current report
Aug 6, 2026 10-Q Quarterly report Jun 30, 2026
Jul 6, 2026 8-K item 3.01 Listing warning from its exchange · Current report Jun 29, 2026
Jun 25, 2026 ARS Annual report to shareholders Dec 31, 2025
Jun 25, 2026 DEFA14A Extra proxy material
Jun 25, 2026 DEF 14A Proxy statement Aug 13, 2026
Jun 25, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report Jun 24, 2026
Jun 11, 2026 PRE 14A Preliminary proxy statement
May 13, 2026 10-Q Quarterly report Mar 31, 2026
May 13, 2026 8-K items 2.02, 9.01 Results released · Current report
Apr 15, 2026 10-K/A Annual report, amended Dec 31, 2025
Apr 2, 2026 8-K item 3.01 Listing warning from its exchange · Current report Apr 1, 2026
Mar 30, 2026 10-K Annual report Dec 31, 2025
Mar 25, 2026 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Feb 13, 2026 SCHEDULE 13G/A Large holder update, amended
Nov 13, 2025 10-Q Quarterly report Sep 30, 2025
Nov 13, 2025 8-K items 2.02, 9.01 Results released · Current report
Oct 3, 2025 8-K item 3.01 Listing warning from its exchange · Current report Oct 2, 2025
Sep 16, 2025 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
Aug 20, 2025 8-K items 8.01, 9.01 Other event · Current report Aug 14, 2025
Aug 7, 2025 10-Q Quarterly report Jun 30, 2025
Aug 7, 2025 8-K items 2.01, 9.01 Purchase or sale of a business completed · Current report
Aug 1, 2025 8-K items 8.01, 9.01 Other event · Current report Jul 31, 2025
Jul 2, 2025 8-K items 8.01, 9.01 Other event · Current report
Jun 24, 2025 8-K items 8.01, 9.01 Other event · Current report
Jun 13, 2025 8-K item 5.07 Shareholder vote · Current report Jun 12, 2025
Jun 11, 2025 8-K item 7.01 Investor disclosure (Regulation FD) · Current report Jun 10, 2025
May 28, 2025 SCHEDULE 13G Large holder notice
May 14, 2025 10-Q Quarterly report Mar 31, 2025
May 14, 2025 8-K items 2.02, 9.01 Results released · Current report
May 1, 2025 8-K items 8.01, 9.01 Other event · Current report Apr 25, 2025
Apr 30, 2025 SCHEDULE 13G/A Large holder update, amended
Apr 23, 2025 ARS Annual report to shareholders Dec 31, 2024
Apr 23, 2025 DEFA14A Extra proxy material
Apr 23, 2025 DEF 14A Proxy statement Jun 12, 2025
40 of 320 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton CTSO · research, not advice